# 510(k) Summary K102841

# Submitted By:

Pantex, Division of Bio-Analysis, Inc.   
1701. Berkeley Street   
Santa Monica, CA 90404   
USA   
(310) 828-7423   
Romulo Garza, Ph.D., President/Senior Scientist

Company Contact:

Date Summary Prepared:

4-3-12

Trade Name:

Pantex AM/PM Salivary Cortisol EIA Kit

Common Name:

Enzyme immunoassay, cortisol, salivary

Regulation Number and Panel:

862.1205-Clinical Chemistry

Classification Product Code:

NHG

Classification:

Class II

Substantially Equivalent Device:

K01 1323 Salimetrics HS Salivary Cortisol EIA Kit Item No. 1-3102 (single) 96 well kit

Device Description:

# A. Test principle.

The basis of the Cortisol Enzyme Immunoassay (EIA) is the quantitative relation between ligand concentration and the proportion of Cortisol (analog) enzyme conjugate bound to the antiserum. For example: Cortisol in the calibrators and unknowns compete with Cortisol coupled to peroxidase for antibody binding sites.After incubation, unbound components are washed away. The reaction between Corisol peroxidase with the substrate TMB) produces a blue color.The pre-determined time of incubation the reaction is stopped and a yellow color is formed. The optical density (read at $4 5 0 ~ \mathrm { n m } )$ is inversely proportional to the cortisol of calibrators, saliva samples and saliva controls.

# B.Kit Description.

The kit consists of a 96 well GARGG (Goat Anti-Rabbit Gamma Globulin) coated microplate (12x8 breakable strip wells), seven ready-to-use calibrators (range $0 . 1 { - } 3 0 ~ \mathrm { n g / m l } )$ of gravimetrically prepared cortisol from a commercial source (Steraloids) and compared and traced to NIST cortisol, low and high controls, anti-Cortisol (rabbit), 10X concentrated Cortisol (analog)-peroxidase, substrate solution, stop reaction solution and 10X concentrated wash solution.

# C. Intended Use/Indications for Use:

For then-vitro diagnostic quantitative determinationo free and proten bound salivary cortisol in uman saliva as an aid in the assessment of Cushing Syndrome and Addison's Disease. Measurements of cortisol in saliva are used in the diagnosis and treatment of disorders of the adrenal gland.

# Predicate Device:

The predicate device for substantial equivalence in this submission is:

<table><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>Salimetrics Salivary Cortisol HS ElA Kit</td></tr><tr><td rowspan=1 colspan=1>Company</td><td rowspan=1 colspan=1>Salimetrics</td></tr><tr><td rowspan=1 colspan=1>510(k) reference</td><td rowspan=1 colspan=1>K011323</td></tr></table>

# Technology Comparison:

<table><tr><td colspan="3" rowspan="1">echnology Comparison:</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate Device:Salimetrics Salivary Cortisol HSEIA Kit(K011323)</td><td colspan="1" rowspan="1">New Device:Pantex AM/PM SalivaryCortisol EIA Kit(K102841) pending</td></tr><tr><td colspan="1" rowspan="1">Indications for use</td><td colspan="1" rowspan="1">For the in-vitro diagnosticquantitative determination of freeand protein bound salivarycortisol in human saliva as an aidin the assessment of CushingSyndrome and Addison's Disease.Measurement s of cortisol insaliva are used in the diagnosisand treatment of disorders of theadrenal gland.</td><td colspan="1" rowspan="1">For the in-vitro diagnosticquantitative determination offree and protein boundsalivary cortisol in humansaliva as an aid in theassessment of CushingSyndrome and Addison'sDisease.Measurement s of cortisol insaliva are used in the diagnosisand treatment of disorders ofthe adrenal gland.</td></tr><tr><td colspan="1" rowspan="1">Analyte</td><td colspan="1" rowspan="1">Free and Protein-boundCortisol</td><td colspan="1" rowspan="1">Free and Protein-boundCortisol</td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Saliva</td><td colspan="1" rowspan="1">Saliva</td></tr><tr><td colspan="1" rowspan="1">Method</td><td colspan="1" rowspan="1">Enzyme immunoassay</td><td colspan="1" rowspan="1">Enzyme immunoassay</td></tr><tr><td colspan="1" rowspan="1">Detection Method</td><td colspan="1" rowspan="1">Colormetric microplate reader</td><td colspan="1" rowspan="1">Colormetric microplate reader</td></tr><tr><td colspan="1" rowspan="1">Test Principle</td><td colspan="1" rowspan="1">Cortisol in the sample competeswith Cortisol-enzyme conjugatefor binding sites to antibodybound to a microwell. Unboundcomponents are washed away andenzyme is measured by a coloredreaction with the TMB substrate.</td><td colspan="1" rowspan="1">Cortisol in the samplecompetes with cortisol-enzyme conjugate for bindingsites to the antibody (rabbitanti cortisol) bound to aGARGG microplate.Unbound components arewashed away and enzyme ismeasured by a coloredreaction with the TMBsubstrate.</td></tr><tr><td colspan="1" rowspan="1">Calculations</td><td colspan="1" rowspan="1">Quantitative determinationwith standard curve</td><td colspan="1" rowspan="1">Quantitative determinationwith standard curve</td></tr><tr><td colspan="1" rowspan="1">Quality Control</td><td colspan="1" rowspan="1">Use of reference controls isrecommended</td><td colspan="1" rowspan="1">Use of reference controls isrecommended</td></tr><tr><td colspan="1" rowspan="1">Analytical MeasuringRange (AMR)</td><td colspan="1" rowspan="1">0.12 ng/ml - 30.0 ng/ml</td><td colspan="1" rowspan="1">0.1 ng/ml - 30.0 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Expected Values(Normal range)</td><td colspan="1" rowspan="1">N=192Ages: 18-70AM range: 0.8 - 15.5 ng/mlPM range: &lt;0.12 - 3.6 ng/ml</td><td colspan="1" rowspan="1">N=152Ages: 23 - 68AM range: 2.58 - 12.69 ng/mlPM range: 0.25 - 2.96 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Limits of Detection</td><td colspan="1" rowspan="1">Limit of Blank (LoB)not calculated</td><td colspan="1" rowspan="1">Limit of Blank (LoB)0.0392 ng/ml</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Limit of Detection (LoD)not calculatedLimit of Quantitation (LoQ)not calculated</td><td colspan="1" rowspan="1">Limit of Detection (LoD)0.0519 ng/mlLimit of Quantitation (LoQ)0.0519 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Saliva Collection Device</td><td colspan="1" rowspan="1">Polypropylene vials andSalimetrics oral swab (SOS), Item# 5001.02</td><td colspan="1" rowspan="1">VWR Sample Mailing TubeCat #16465-260</td></tr><tr><td colspan="1" rowspan="1">Interferences</td><td colspan="1" rowspan="1">Information not available inSalimetric's package insert</td><td colspan="1" rowspan="1">An in-vitro spiking study withhigh doses of caffeine, food,nicotine, alcohol and chewinggum did not reveal significantinterference in themeasurement of cortisol insaliva using the PantexAM/PM Salivary Cortisol EIAKit Cat #631.</td></tr><tr><td colspan="1" rowspan="1">Stability and Storage ofKit Reagents (open vial)</td><td colspan="1" rowspan="1">Stated as stable at 2°-8°C until thekit's expiration date</td><td colspan="1" rowspan="1">The stability of the opened kitreagents were determined tobe 3 1 days when stored at 2°-8°C using Pantex AM/PMSalivary Cortisol EIA Kit Cat#631.</td></tr></table>

# Test Summary:

# Performance Characteristics

The performance characteristics of Pantex AM/PM Salivary Cortisol Enzyme Immunoassay were based on evaluations by the following analytical performance tests.

I. Analytical Performance Precision/Repeatability Intra-assay Inter-assay Inter-lot variation Linearity Recovery Traceability, Reagent Stability, Sample Stability and Expected values Detection Limits Analytical Specificity/Cross Reactivity

II.Method Comparison

III. Interferences

I. Analytical Performance aPrecision/Reproducibility

(i) The intra-assay precision was determined from 20 replicates of low, medium and high samples.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean (ng/mL)</td><td rowspan=1 colspan=1>StandardDeviation (ng/mL)</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0.627</td><td rowspan=1 colspan=1>0.034</td><td rowspan=1 colspan=1>5.4</td></tr><tr><td rowspan=1 colspan=1>Medium</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>3.995</td><td rowspan=1 colspan=1>0.266</td><td rowspan=1 colspan=1>6.7</td></tr><tr><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>25.232</td><td rowspan=1 colspan=1>1.579</td><td rowspan=1 colspan=1>6.3</td></tr></table>

(iiThe inter-assay precision was determined from the mean of average duplicates for twelve (12) separate assays.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean (ng/mL)</td><td rowspan=1 colspan=1>StandardDeviation (ng/mL)</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.587</td><td rowspan=1 colspan=1>0.037</td><td rowspan=1 colspan=1>6.3</td></tr><tr><td rowspan=1 colspan=1>Medium</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>4.163</td><td rowspan=1 colspan=1>0.301</td><td rowspan=1 colspan=1>7.2</td></tr><tr><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>12  •</td><td rowspan=1 colspan=1>25.126</td><td rowspan=1 colspan=1>0.712</td><td rowspan=1 colspan=1>2.8</td></tr></table>

(iii) The inter-lot or between-lot variation was determined by duplicate measurements of five pools of saliva samples and three (3) saliva controls using three (3) different lots.The results of intra-assay, inter-assay and inter-lot variation concluded a $\% C V$ of $\leq 1 0 \%$ for each sample tested.

<table><tr><td rowspan=1 colspan=1>Salivasamples</td><td rowspan=1 colspan=1>Lot #012</td><td rowspan=1 colspan=1>Lot #013</td><td rowspan=1 colspan=1>Lot #014</td><td rowspan=1 colspan=1>Inter-lot</td><td rowspan=1 colspan=1>Inter-lot</td><td rowspan=1 colspan=1>Inter-lot</td></tr><tr><td rowspan=1 colspan=1>ID</td><td rowspan=1 colspan=1>Mean(ng/ml)</td><td rowspan=1 colspan=1>Mean(ng/ml)</td><td rowspan=1 colspan=1>Mean(ng/ml)</td><td rowspan=1 colspan=1>Mean(ng/ml)</td><td rowspan=1 colspan=1>Std.Dev.(ng/ml)</td><td rowspan=1 colspan=1>CV(%)</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>4.65</td><td rowspan=1 colspan=1>4.45</td><td rowspan=1 colspan=1>4.79</td><td rowspan=1 colspan=1>4.64</td><td rowspan=1 colspan=1>0.164</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>0.67</td><td rowspan=1 colspan=1>0.61</td><td rowspan=1 colspan=1>0.71</td><td rowspan=1 colspan=1>0.67</td><td rowspan=1 colspan=1>0.049</td><td rowspan=1 colspan=1>7.4</td></tr><tr><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>2.02</td><td rowspan=1 colspan=1>1.95</td><td rowspan=1 colspan=1>2.09</td><td rowspan=1 colspan=1>2.02</td><td rowspan=1 colspan=1>0.069</td><td rowspan=1 colspan=1>3.4</td></tr><tr><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>4.75</td><td rowspan=1 colspan=1>4.69</td><td rowspan=1 colspan=1>4.76</td><td rowspan=1 colspan=1>4.73</td><td rowspan=1 colspan=1>0.041</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>2.01</td><td rowspan=1 colspan=1>1.99</td><td rowspan=1 colspan=1>2.04</td><td rowspan=1 colspan=1>2.01      :</td><td rowspan=1 colspan=1>0.026</td><td rowspan=1 colspan=1>1.3</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>3.64</td><td rowspan=1 colspan=1>3.67</td><td rowspan=1 colspan=1>3.71</td><td rowspan=1 colspan=1>3.68</td><td rowspan=1 colspan=1>0.036</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>LC</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>0.036</td><td rowspan=1 colspan=1>3.7</td></tr><tr><td rowspan=1 colspan=1>NC</td><td rowspan=1 colspan=1>5.21</td><td rowspan=1 colspan=1>5.31</td><td rowspan=1 colspan=1>5.49</td><td rowspan=1 colspan=1>5.34</td><td rowspan=1 colspan=1>0.140</td><td rowspan=1 colspan=1>2.6</td></tr><tr><td rowspan=1 colspan=1>HC</td><td rowspan=1 colspan=1>10.79</td><td rowspan=1 colspan=1>10.13</td><td rowspan=1 colspan=1>10.52</td><td rowspan=1 colspan=1>10.48</td><td rowspan=1 colspan=1>0.329</td><td rowspan=1 colspan=1>3.1</td></tr></table>

ivRepeatability

This study was conducted during 4 days of familiarization period and 20 days of testing. Two assays were performed daily with a minimum of 2 hours between assays. Three (3) different reagents lots and three (3) saliva pools were used for the study (Low, medium and high concentration). The pools were aliquoted and frozen until day of assay.

<table><tr><td rowspan=1 colspan=2>Repeatability Low Concentration</td></tr><tr><td rowspan=1 colspan=1>Concentration (ng/ml)</td><td rowspan=1 colspan=1>0.600</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation</td><td rowspan=1 colspan=1>0.0141</td></tr><tr><td rowspan=1 colspan=1>(l) (User Variance/Claim Variance) x R</td><td rowspan=1 colspan=1>62.695</td></tr><tr><td rowspan=1 colspan=1>(II) Critical Chi-square</td><td rowspan=1 colspan=1>65.171</td></tr><tr><td rowspan=1 colspan=1>Claim Rejected ([&gt;il)</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Claim Accepted (K&lt;II)</td><td rowspan=1 colspan=1>Yes</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Precision Low Concentration Pool</td></tr><tr><td rowspan=1 colspan=1>EY</td><td rowspan=1 colspan=1>Standard Deviation, SD)</td><td rowspan=1 colspan=1>(% Coefficient of Variation CV)</td></tr><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>0.0224</td><td rowspan=1 colspan=1>3.79</td></tr><tr><td rowspan=1 colspan=1>Between Run</td><td rowspan=1 colspan=1>0.0462</td><td rowspan=1 colspan=1>7.80</td></tr><tr><td rowspan=1 colspan=1>Repeatability</td><td rowspan=1 colspan=1>0.0162</td><td rowspan=1 colspan=1>2.73</td></tr><tr><td rowspan=1 colspan=1>Total Device Precision</td><td rowspan=1 colspan=1>0.0538</td><td rowspan=1 colspan=1>9.09</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Repeatability Medium Concentration</td></tr><tr><td rowspan=1 colspan=1>Concentration (ng/ml)</td><td rowspan=1 colspan=1>4.0 ng/ml</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation</td><td rowspan=1 colspan=1>0.0.894</td></tr><tr><td rowspan=1 colspan=1>(l) (User Variance/Claim Variance) x R</td><td rowspan=1 colspan=1>63.073</td></tr><tr><td rowspan=1 colspan=1>(II) Critical Chi-square</td><td rowspan=1 colspan=1>65.171</td></tr><tr><td rowspan=1 colspan=1>Claim Rejected ([&gt;II)</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Claim Accepted (I&lt;II)</td><td rowspan=1 colspan=1>Yes</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Precision Medium Concentration Pool</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Standard Deviation, SD)</td><td rowspan=1 colspan=1>(% Coefficient of Variation CV)</td></tr><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>0.1475</td><td rowspan=1 colspan=1>3.60</td></tr><tr><td rowspan=1 colspan=1>Between Run</td><td rowspan=1 colspan=1>0.0514</td><td rowspan=1 colspan=1>1.26</td></tr><tr><td rowspan=1 colspan=1>Repeatability</td><td rowspan=1 colspan=1>0.1025</td><td rowspan=1 colspan=1>2.50</td></tr><tr><td rowspan=1 colspan=1>Total Device Precision</td><td rowspan=1 colspan=1>0.1869</td><td rowspan=1 colspan=1>4.56</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Repeatability High Concentration</td></tr><tr><td rowspan=1 colspan=1>Concentration (ng/ml)</td><td rowspan=1 colspan=1>25 ng/ml</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation</td><td rowspan=1 colspan=1>0.5477</td></tr><tr><td rowspan=1 colspan=1>(l) (User Variance/Claim Variance) x R</td><td rowspan=1 colspan=1>62.035</td></tr><tr><td rowspan=1 colspan=1>(II) Critical Chi-square</td><td rowspan=1 colspan=1>65.171</td></tr><tr><td rowspan=1 colspan=1>Claim Rejected (&gt;1l)</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Claim Accepted (KII)</td><td rowspan=1 colspan=1>Yes</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Precision High Concentration Pool</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Standard Deviation, SD)</td><td rowspan=1 colspan=1>(% Coefficient of Variation CV)</td></tr><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>0.4442</td><td rowspan=1 colspan=1>1.176</td></tr><tr><td rowspan=1 colspan=1>Between Run</td><td rowspan=1 colspan=1>0.2915</td><td rowspan=1 colspan=1>1.15</td></tr><tr><td rowspan=1 colspan=1>Repeatability</td><td rowspan=1 colspan=1>0.62276</td><td rowspan=1 colspan=1>2.46</td></tr><tr><td rowspan=1 colspan=1>Total Device Precision</td><td rowspan=1 colspan=1>0.8185</td><td rowspan=1 colspan=1>3.24</td></tr></table>

b. Linearity

Ten (10) sample concentrations that span the assay measuring range were performed Per EP6-A, Evaluation of the Linearity of Quantitative Measurement Procedures.

$\mathrm { S } { = } 1 0$ samples (dilutions) Concentration $= ( \mathbf { C } \mathbf { l } ^ { * } \mathbf { V } \mathbf { l } + \mathbf { C } \mathbf { l 0 } ^ { * } \mathbf { V } _ { . } \mathbf { l 0 } ) / ( \mathbf { V } \mathbf { l } + \mathbf { V } \mathbf { l 0 } )$

<table><tr><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>C1ng/ml</td><td rowspan=1 colspan=1>V1ng/ml</td><td rowspan=1 colspan=1>C10ng/ml</td><td rowspan=1 colspan=1>V10ng/ml</td><td rowspan=1 colspan=1>CalculatedConcentrationng/ml</td><td rowspan=1 colspan=1>ObtainedConcentrationng/ml</td><td rowspan=1 colspan=1>Recovery%</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>0.100</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>93.0</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.889</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.111</td><td rowspan=1 colspan=1>3.833</td><td rowspan=1 colspan=1>3.729</td><td rowspan=1 colspan=1>97.3</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.778</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.222</td><td rowspan=1 colspan=1>7.573</td><td rowspan=1 colspan=1>7.620</td><td rowspan=1 colspan=1>100.6</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.667</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.333</td><td rowspan=1 colspan=1>11.313</td><td rowspan=1 colspan=1>10.842</td><td rowspan=1 colspan=1>95.8</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.556</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.444</td><td rowspan=1 colspan=1>15.054</td><td rowspan=1 colspan=1>14.350</td><td rowspan=1 colspan=1>95.3</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.444</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.556</td><td rowspan=1 colspan=1>18.827</td><td rowspan=1 colspan=1>18.313</td><td rowspan=1 colspan=1>97.3</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.333</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.667</td><td rowspan=1 colspan=1>22.568</td><td rowspan=1 colspan=1>21.547</td><td rowspan=1 colspan=1>95.5</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.222</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.778</td><td rowspan=1 colspan=1>26.308</td><td rowspan=1 colspan=1>24.694</td><td rowspan=1 colspan=1>93.9</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0.093</td><td rowspan=1 colspan=1>0.111</td><td rowspan=1 colspan=1>33.788</td><td rowspan=1 colspan=1>0.889</td><td rowspan=1 colspan=1>30.048</td><td rowspan=1 colspan=1>30.459</td><td rowspan=1 colspan=1>101.4</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>35.000</td><td rowspan=1 colspan=1>33.788.</td><td rowspan=1 colspan=1>96.5</td></tr></table>

\*Targets of low and high sample concentrations

# c. Recovery:

Ten (10) saliva samples containing different levels of endogenous cortisol were spiked with known quantities of cortisol and assayed.

<table><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Endogenous(ng/ml</td><td rowspan=1 colspan=1>Added(ng/ml)</td><td rowspan=1 colspan=1>Expected(ng/ml)</td><td rowspan=1 colspan=1>Observed(ng/ml)</td><td rowspan=1 colspan=1>Recovery(%)</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.493</td><td rowspan=1 colspan=1>0.250</td><td rowspan=1 colspan=1>0.743</td><td rowspan=1 colspan=1>0.739</td><td rowspan=1 colspan=1>99.5</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.878</td><td rowspan=1 colspan=1>0.500</td><td rowspan=1 colspan=1>1.378</td><td rowspan=1 colspan=1>1.291</td><td rowspan=1 colspan=1>93.7</td></tr><tr><td rowspan=1 colspan=1>.3</td><td rowspan=1 colspan=1>1.551</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>2.551</td><td rowspan=1 colspan=1>2.641</td><td rowspan=1 colspan=1>103.5</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1.850</td><td rowspan=1 colspan=1>2.000</td><td rowspan=1 colspan=1>3.850</td><td rowspan=1 colspan=1>3.958</td><td rowspan=1 colspan=1>102.8</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0.936</td><td rowspan=1 colspan=1>4.000</td><td rowspan=1 colspan=1>4.936</td><td rowspan=1 colspan=1>4.951</td><td rowspan=1 colspan=1>100.3</td></tr><tr><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>1.042</td><td rowspan=1 colspan=1>8.000</td><td rowspan=1 colspan=1>9.042</td><td rowspan=1 colspan=1>9.394</td><td rowspan=1 colspan=1>103.9</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0.691</td><td rowspan=1 colspan=1>16.000</td><td rowspan=1 colspan=1>16.691</td><td rowspan=1 colspan=1>17.165</td><td rowspan=1 colspan=1>102.8</td></tr><tr><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0.622</td><td rowspan=1 colspan=1>20.000</td><td rowspan=1 colspan=1>20.622</td><td rowspan=1 colspan=1>19.997</td><td rowspan=1 colspan=1>97.0</td></tr><tr><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>2.057</td><td rowspan=1 colspan=1>24.000</td><td rowspan=1 colspan=1>26.057</td><td rowspan=1 colspan=1>24.938</td><td rowspan=1 colspan=1>95.7</td></tr><tr><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0.348</td><td rowspan=1 colspan=1>28.000</td><td rowspan=1 colspan=1>28.348</td><td rowspan=1 colspan=1>28.943</td><td rowspan=1 colspan=1>102.1</td></tr></table>

d. Traceability/Reagent Stability/Sample Stability/Expected Values The calibrators and controls are prepared from stock cortisol (Steraloids) and are gravimetrically weighed and prepared. Concentration of stock cortisol (Steraloids) concentrations were confirmed by comparison to NIST cortisol $( \mathsf { y } { = } 1 . 0 2 9 \ \mathsf { x } { - } 0 . 2 1 9 5 . \ \mathsf { R } ^ { 2 } { = } 0 . 9 9 2 4 )$

Summary of the stability results

Real time stability studies are conducted to determine the reagent and kit shelf life (expiration date). Expiration date of the Pantex AM/PM Salivary Cortisol EIA Kit, Cat 631, is determined by results of shelf lie sudies and is based on the reagent that has the shorter assigned expiraton day.

1. The reagents stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ are stable for 9 months; therefore, the expiration date of the kit components is established at 9 months from the manufacturing date. We are basing the 9 month stability claim based on the results obtained with the real time stability study when stored at $2 { \cdot } 8 ^ { \circ } \mathrm { C }$ , supported by the reagents stored at room temperature $( 2 0 - 2 8 ^ { \circ } \mathrm { C } )$ and in reference to the stress chart that predicts reagents year stability at $+ 5 ^ { \circ } \mathrm { C }$ , by Kennon, L. "Use of models in determining chemical pharmaceutical stability".

Sample stability

Four ()stress conditions on freshly collected saliva revealed the following:   

<table><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>RoomTemperature20 - 30 °C</td><td rowspan=1 colspan=1>37 °C</td><td rowspan=1 colspan=1>2-8°C</td><td rowspan=1 colspan=1>≤-15 °C(7 freeze / thawcycles)</td><td rowspan=1 colspan=1>≤-15°C(Long term)</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Up to 7 days</td><td rowspan=1 colspan=1>Up to 7days</td><td rowspan=1 colspan=1>Up to 7days</td><td rowspan=1 colspan=1>Up to 7 days</td><td rowspan=1 colspan=1>Up to 180 days</td></tr></table>

Open vial and working Cortisol-HRP Conjugate solution stability determination.   

<table><tr><td rowspan=1 colspan=1>Condition</td><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Storage Temperature</td></tr><tr><td rowspan=1 colspan=1>Reagents. Open vial stability</td><td rowspan=1 colspan=1>31 days</td><td rowspan=1 colspan=1>2-8 °C</td></tr><tr><td rowspan=1 colspan=1>Working Cortisol-HRP conjugate solution</td><td rowspan=1 colspan=1>31 days</td><td rowspan=1 colspan=1>2-8 °</td></tr></table>

Expected Reference Values:

The reference range was re-established by testing 152 male saliva samples and 152 female samples to have an equal number of male and female samples. The reference range and median were recalculated using CLSI C28-A3 as a guide. The following tables indicate the summary of the results

AM Expected Values:   

<table><tr><td rowspan=1 colspan=1>Subjects(Number)</td><td rowspan=1 colspan=1>Subjects(Gender)</td><td rowspan=1 colspan=1>Age(Years)</td><td rowspan=1 colspan=1>AM Median(ng/mL)</td><td rowspan=1 colspan=1>AM Range(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>152</td><td rowspan=1 colspan=1>76 Males76 Females</td><td rowspan=1 colspan=1>23-68</td><td rowspan=1 colspan=1>6.70</td><td rowspan=1 colspan=1>2.58 - 12.69</td></tr></table>

PM Expected Values:   

<table><tr><td rowspan=1 colspan=1>Subjects(Number)</td><td rowspan=1 colspan=1>Subjects(Gender)</td><td rowspan=1 colspan=1>Age(Years)</td><td rowspan=1 colspan=1>PM Median(ng/mL)</td><td rowspan=1 colspan=1>PM Range(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>152</td><td rowspan=1 colspan=1>76 Males76 Females</td><td rowspan=1 colspan=1>23-68</td><td rowspan=1 colspan=1>0.58</td><td rowspan=1 colspan=1>0.25 - 2.96</td></tr></table>

e. Detection Limits

The LoB (limit of the blank), the LoD (limit of detection) and the LoQ (limit of quantitation) were determined by generating one hundred and twenty (120) measurements each of "cortisol free free salvia and low level $( < 0 . 1 \ \mathrm { n g / m l } )$ cortisol samples (Reference, CLSI EP1 7-A, protocols for Determination of Limits of Detection and Limits of Quantitation).

<table><tr><td>Limits of Blank (LoB) ng/mL</td><td>Limits of Detection (LoD) ng/mL</td><td>Limits of Quantitation (LoQ) ng/mL</td></tr><tr><td>0.0392</td><td>0.0519</td><td>0.0519</td></tr></table>

# f. Analytical Specificity/Cross Reactivity

Cross-reactivity was determined by testing those compounds most like to interfere with the Pantex AM/PM Salivary Cortisol ElA Kit. The specificity of the antiserum was evaluated by evaluating the cross-reactivity expressed as ratios of concentration of unlabeled cortisol over the compound that displaces $50 \%$ of cortisol-enzyme conjugate from the antiserum.

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Spiked Concentration</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>C-21 Steroids</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E</td></tr><tr><td rowspan=1 colspan=1>Cortisol</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>100.0000</td></tr><tr><td rowspan=1 colspan=1>17-OH-Progesterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0284</td></tr><tr><td rowspan=1 colspan=1>Pregnenolone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0038</td></tr><tr><td rowspan=1 colspan=1>17-OH-Pregnenolone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0066</td></tr><tr><td rowspan=1 colspan=1>Progesterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0079</td></tr><tr><td rowspan=1 colspan=1>Desoxycorticosterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0517</td></tr><tr><td rowspan=1 colspan=1>11-Desoxycortisol</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>1.8133</td></tr><tr><td rowspan=1 colspan=1>Dexamethasone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0164</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.7600</td></tr><tr><td rowspan=1 colspan=1>Corticosterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>1.0847</td></tr><tr><td rowspan=1 colspan=1>Aldosterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0070</td></tr><tr><td rowspan=1 colspan=1>C-19 Steroids</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Androstenedione</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0038</td></tr><tr><td rowspan=1 colspan=1>Testosterone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0042</td></tr><tr><td rowspan=1 colspan=1>SαDHT</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0019</td></tr><tr><td rowspan=1 colspan=1>DHEA-SO4</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0031</td></tr><tr><td rowspan=1 colspan=1>Androstanedione</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0028</td></tr><tr><td rowspan=1 colspan=1>C-18 Steroids</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Estradiol 17β</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0024</td></tr><tr><td rowspan=1 colspan=1>Estradiol 17α</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0003</td></tr><tr><td rowspan=1 colspan=1>Estrone</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0010</td></tr><tr><td rowspan=1 colspan=1>Estriol</td><td rowspan=1 colspan=1>10,000 ng/ml</td><td rowspan=1 colspan=1>0.0015</td></tr><tr><td rowspan=1 colspan=1>Other structurally related steroids</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Dehydroisoandrosterone</td><td rowspan=1 colspan=1>1000 ng/ml</td><td rowspan=1 colspan=1>0.0076</td></tr><tr><td rowspan=1 colspan=1>6αmethyl-17-Hydroxyprogesterone</td><td rowspan=1 colspan=1>1000 ng/ml</td><td rowspan=1 colspan=1>0.1427</td></tr><tr><td rowspan=1 colspan=1>6β Hydroxycortisol</td><td rowspan=1 colspan=1>1000 ng/ml</td><td rowspan=1 colspan=1>1.7177</td></tr><tr><td rowspan=1 colspan=1>Prednisone</td><td rowspan=1 colspan=1>1000 ng/ml</td><td rowspan=1 colspan=1>1.0874</td></tr><tr><td rowspan=1 colspan=1>Prednisolone</td><td rowspan=1 colspan=1>1000 ng/ml</td><td rowspan=1 colspan=1>25.9001</td></tr></table>

At $> 1 0 \%$ cross reaction prednisolone is a potential interfering substance.

Tests were conducted for comparison between the Pantex AM/PM Salivary Cortisol EIA Kit, Cat and the predicate assay , Salimetrics HS Salivary Cortisol EIA. The cortisol results of 160 samples were compared . Comparison of the Pantex AM/PM Salivary Cortisol EIA Kit (new device) and the Salimetrics HS Salivary Cortisol EIA (predicate) demonstrated acceptable regression and correlation statistics and appears to be substantially equivalent to the FDA cleared predicate device.

<table><tr><td rowspan=1 colspan=2>Pantex AM/PM Salivary Cortisol EIA versus Salimetrics HS Salivary Cortisol EIA</td></tr><tr><td rowspan=1 colspan=1>Linear Regression equation</td><td rowspan=1 colspan=1>Y = 1.0269x + 0.0994</td></tr><tr><td rowspan=1 colspan=1>Correlation (r²)</td><td rowspan=1 colspan=1>0.9797</td></tr></table>

III. Interferences Studies.

An in-vitro experiment was performed by spiking three (3) levels of Cortisol (low, medium and high) with svpelintusacocf c nicotine) an fod and gum extracts.The results obtaine appear to demonstrate o significant interence of the substances tested in this study with the measurement of Cortisol in saliva using the Pantex AM/PM Salivary Cortisol ElA Kit, Cat $\# 6 3 1$ .

In-vitro experiment results:

<table><tr><td colspan="1" rowspan="1">Pools</td><td colspan="1" rowspan="1">Potential InterferentCaffeine Added(ug/mL)</td><td colspan="1" rowspan="1">Obtained Value(ng/mL)</td><td colspan="1" rowspan="1">Recovery fromControl(%)</td></tr><tr><td colspan="1" rowspan="1">Low Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1.420</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">1.444</td><td colspan="1" rowspan="1">101.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">1.438</td><td colspan="1" rowspan="1">101.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">1.477</td><td colspan="1" rowspan="1">104.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">′</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Middle Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4.932</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">5.143</td><td colspan="1" rowspan="1">104.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">5.063</td><td colspan="1" rowspan="1">102.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">4.539</td><td colspan="1" rowspan="1">92.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">High Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">28.302</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">26.010</td><td colspan="1" rowspan="1">91.9</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">26.811</td><td colspan="1" rowspan="1">94.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">27.563</td><td colspan="1" rowspan="1">97.4</td></tr><tr><td colspan="1" rowspan="1">Pools</td><td colspan="1" rowspan="1">Potential InterferentFood Added(mg/mL)</td><td colspan="1" rowspan="1">Obtained Value(ng/mL)</td><td colspan="1" rowspan="1">Recovery fromControl(%)</td></tr><tr><td colspan="1" rowspan="1">Low Pool</td><td colspan="1" rowspan="1">0.000</td><td colspan="1" rowspan="1">1.345</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">1.340</td><td colspan="1" rowspan="1">99.6</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">213</td><td colspan="1" rowspan="1">1.332</td><td colspan="1" rowspan="1">99.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">106.5</td><td colspan="1" rowspan="1">1.291</td><td colspan="1" rowspan="1">96.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Middle Pool</td><td colspan="1" rowspan="1">0.000</td><td colspan="1" rowspan="1">4.739</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">4.730</td><td colspan="1" rowspan="1">99.8</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">213</td><td colspan="1" rowspan="1">4.834</td><td colspan="1" rowspan="1">102.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">106.5</td><td colspan="1" rowspan="1">4.835</td><td colspan="1" rowspan="1">102.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">High Pool</td><td colspan="1" rowspan="1">0.000</td><td colspan="1" rowspan="1">26.447</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">27.495</td><td colspan="1" rowspan="1">104.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">213</td><td colspan="1" rowspan="1">26.283</td><td colspan="1" rowspan="1">99.4</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">106.5</td><td colspan="1" rowspan="1">28.055</td><td colspan="1" rowspan="1">106.1</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Pools</td><td colspan="1" rowspan="1">Potential InterferentNicotineAdded(ug/mL)</td><td colspan="1" rowspan="1">Obtained Value(ng/mL)</td><td colspan="1" rowspan="1">Recovery fromControl(%)</td></tr><tr><td colspan="1" rowspan="1">Low Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1.362</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">1.436</td><td colspan="1" rowspan="1">101.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">1.437</td><td colspan="1" rowspan="1">101.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">1.4345</td><td colspan="1" rowspan="1">104.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">1.317</td><td colspan="1" rowspan="1">96.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Middle Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4.871</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">5.243</td><td colspan="1" rowspan="1">107.6</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">5.258</td><td colspan="1" rowspan="1">107.9</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">5.087</td><td colspan="1" rowspan="1">104.4</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">5.155</td><td colspan="1" rowspan="1">105.8</td></tr><tr><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">EPY</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">High Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">25.503</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">27.033</td><td colspan="1" rowspan="1">106.0</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">26.397</td><td colspan="1" rowspan="1">103.5</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">25.642</td><td colspan="1" rowspan="1">100.6</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">24.928</td><td colspan="1" rowspan="1">97.8</td></tr><tr><td colspan="1" rowspan="1">Pools</td><td colspan="1" rowspan="1">Potential InterferentGum Added(mg/mL)</td><td colspan="1" rowspan="1">Obtained Value(ng/mL)</td><td colspan="1" rowspan="1">Recovery fromControl(%)</td></tr><tr><td colspan="1" rowspan="1">Low Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1.289</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">270</td><td colspan="1" rowspan="1">1.346</td><td colspan="1" rowspan="1">104.4</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">135</td><td colspan="1" rowspan="1">1.286</td><td colspan="1" rowspan="1">99.8</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">67.5</td><td colspan="1" rowspan="1">1.248</td><td colspan="1" rowspan="1">96.8</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">33.75</td><td colspan="1" rowspan="1">1.280</td><td colspan="1" rowspan="1">99.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Middle Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4.843</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">270</td><td colspan="1" rowspan="1">4.957</td><td colspan="1" rowspan="1">102.4</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">135</td><td colspan="1" rowspan="1">4.845</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">67.5</td><td colspan="1" rowspan="1">4.712</td><td colspan="1" rowspan="1">97.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">33.75</td><td colspan="1" rowspan="1">4.764</td><td colspan="1" rowspan="1">98.4</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">High Pool</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">28.367</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">270</td><td colspan="1" rowspan="1">29.419</td><td colspan="1" rowspan="1">103.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">135</td><td colspan="1" rowspan="1">29.247</td><td colspan="1" rowspan="1">103.1</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">67.5</td><td colspan="1" rowspan="1">27.870</td><td colspan="1" rowspan="1">98.3</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">33.75</td><td colspan="1" rowspan="1">28.216</td><td colspan="1" rowspan="1">99.5</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Pools</td><td rowspan=1 colspan=1>Potential InterferentEthanol Added(%)</td><td rowspan=1 colspan=1>Obtained Value(ng/mL)</td><td rowspan=1 colspan=1>Recovery fromControl(%)</td></tr><tr><td rowspan=1 colspan=1>Low Pool</td><td rowspan=1 colspan=1>. 0</td><td rowspan=1 colspan=1>1.268</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.025</td><td rowspan=1 colspan=1>1.267</td><td rowspan=1 colspan=1>104.4</td></tr><tr><td rowspan=1 colspan=1>cYanmaGlow</td><td rowspan=1 colspan=1>0.050</td><td rowspan=1 colspan=1>1.230</td><td rowspan=1 colspan=1>99.8</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.100</td><td rowspan=1 colspan=1>1.213</td><td rowspan=1 colspan=1>96.8</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Middle Pool</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.539</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.025</td><td rowspan=1 colspan=1>4.403</td><td rowspan=1 colspan=1>102.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.050</td><td rowspan=1 colspan=1>4.320</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.100</td><td rowspan=1 colspan=1>4.490</td><td rowspan=1 colspan=1>97.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>High Pool</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>26.272</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>canmaentaYlowb</td><td rowspan=1 colspan=1>0.025</td><td rowspan=1 colspan=1>28.362</td><td rowspan=1 colspan=1>108.0</td></tr><tr><td rowspan=1 colspan=1>canmaentaYelowb</td><td rowspan=1 colspan=1>0.050</td><td rowspan=1 colspan=1>28.744</td><td rowspan=1 colspan=1>109.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.100</td><td rowspan=1 colspan=1>28.750</td><td rowspan=1 colspan=1>109.4</td></tr></table>

# Concluding Statement:

Taken together, the performance characteristics, comparison studies with a predicate device and acceptable statistical performance studies in this $5 1 0 ( \mathbf { k } )$ submission demonstrates that the Pantex AM/PM Salivary Cortisol EIA Kit, Cat $\# 6 3 1$ , is safe and effective for its intended use and is substantially equivalent to the predicate device.

Pantex, Division of Bio-Analysis, Inc   
c/o Romulo Garza   
1701 Berkeley Street   
Santa Monica, CA 90404

Re: k102841 Trade Name: Pantex AM/PM Salivary Cortisol Enzyme Immunoassay Regulation Number: 21 CFR $\ S 8 6 2 . 1 2 0 5$ EPY Regulation Name: Cortisol (hydrocortisone and hydroxycorticosterone) test system Regulatory Class: Class II Product Codes: NHG Dated: April 3, 2012 Received: May 2, 2012

Dear Dr. Garza:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

M

Coupney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indications for Use

510(k) Number (if known): _ K102841

# Device Name: Pantex AM/PM Salivary Cortisol Enzyme Immumoassay

Indications For Use:

For the in-vitro diagnostic quantitative determination of free and protein bound salivary cortisol in human saliva as an aid in the assessment of Cushing Syndrome and Addison's Disease. Measurements of cortisol in saliva are used in the diagnosis and treatment of disorders of the adrenal gland.

Prescription Use X And/Or (21 CFR Part 801 Subpart D) .

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/383c5f4572904f0b3c0c48ff615c161c1c108824cc0e56865281833f3d721a67.jpg)

Division Sign-Off   
Office of In Vitro Diagniostic Device   
Evaluation and Safety 102841   
510(k)